biological activity | PBIT is a specific tremonji/AT enrichment interaction domain 1 (JARID1) inhibitor. PBIT inhibits JARID1B (KDM5B or PLU1) histone demethylase with an IC50 value of approximately 3 μm. PBIT also inhibited JARID1A and JARID1C with an IC50 of 6 μm and 4.9 μm, respectively. |
Target | IC50: 3 μm (JARID1B), 6 μm (JARID1A), 4.9 μm (JARID1C) |
Cell Line:
| Human breast cancer cell lines (UACC-812 and MCF7) and human mammary epithelial cells (MCF10A) |
Concentration:
| 1, 3, and 10 μM for UACC-812 cells; 2.5, 5, and 10 μM for MCF7 and MCF10A cells |
Incubation Time:
| 72 hours |
Result:
| Inhibited cell proliferation in a JARID1B level-dependent manner. 10 μM killed most of the UACC-812 cells, but showed minimal toxicity to MCF7 cells and MCF10A cells. |